Orexigen Therapeutics Inc. said Tuesday it is reviving its previously abandoned weight loss drug Contrave, after federal health officials outlined a plan that could bring the drug to market by 2014.

The surprise announcement returns Contrave to the race to be the first new prescription weight loss drug to reach the U.S. market in more than a decade.

Drugmaker revives obesity pill rejected by FDA – USATODAY.com